The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bluebird bio Inc shares valued at $2,289 were sold by Colvin Richard A on Mar 03 ’25. At $3.92 per share, Colvin Richard A sold 584 shares. The insider’s holdings dropped to 7,610 shares worth approximately $37821.7 following the completion of this transaction.
Also, Klima Thomas J sold 500 shares, netting a total of over 1,960 in proceeds. Following the sale of shares at $3.92 each, the insider now holds 7,878 shares.
Before that, Obenshain Andrew had sold 921 shares from its account. In a trade valued at $3,610, the President and CEO traded Bluebird bio Inc shares for $3.92 each. Upon closing the transaction, the insider’s holdings decreased to 921 shares, worth approximately $91085.19.
As published in a research note from JP Morgan on February 24, 2025, Bluebird bio Inc [BLUE] has been rated up from an Underweight to a Neutral. Analysts at JP Morgan downgraded the stock from ‘”a Neutral”‘ to ‘”an Underweight”‘ outlook in a report released in mid November. As of November 15, 2024, BofA Securities has decreased its “Buy” rating to a “Neutral” for BLUE. Earlier on August 15, 2024, JP Morgan downgraded its rating. Their new recommendation was “a Neutral” for BLUE stock which previously was a “an Overweight”.
Analyzing BLUE Stock Performance
Over the course of the year, Bluebird bio Inc shares have dropped approximately -40.41%. Shares of the company reached a 52-week high of $10.28 on 01/06/25 and a 52-week low of $3.20 on 05/13/25.
Support And Resistance Levels for Bluebird bio Inc (BLUE)
According to the 24-hour chart, there is a support level at 4.59, which, if violated, would cause prices to drop to 4.20. In the upper region, resistance lies at 5.17. The next price resistance is at 5.36. RSI (Relative Strength Index) is 62.84 on the 14-day chart, showing neutral technical sentiment.
